Zusammenfassung
Indikationen, Wirkungsweise, Nebenwirkungen und Risiken, Kontraindikationen und Interaktionen werden für die Antidementiva im allgemeinen Teil und dann für jedes Arzneimittel spezifisch im Präparateteil beschrieben.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsLiteratur
Afzal S, Bojesen SE, Nordestgaard BG (2014) Reduced 25-hydroxyvitamin D and risk of Alzheimer’s disease and vascular dementia. Alzheimers Dement 10(3): 296–302
Cooper C, Li R, Lyketsos C, Livingston G (2013) Treatment for mild cognitive impairment: systematic review. Br J Psychiatry 203: 255–264
Hefner G, Brueckner A, Hiemke C, Fellgiebel A (2015) Therapeutic drug monitoring for patients with Alzheimer dementia to improve treatment with donepezil. Ther Drug Monit 37(3): 353–361
Lange-Asschenfeldt C (2013) Vaskuläre Faktoren in der Pathogenese der Alzheimer-Krankheit. Nervenarzt 84(6): 732–737
Monsell SE, Kukull WA, Roher AE et al (2015) Characterizing apolipoprotein E ε4 carriers and noncarriers with the clinical diagnosis of mild to moderate Alzheimer dementia and minimal β-amyloid peptide plaques. JAMA Neurol 72(10): 1124–1131
Nordström P, Religa D, Wimo A et al (2013) The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer’s disease. Eur Heart J 34(33): 2585–2591
Porsteinsson AP, Drye LT, Pollock BG et al; CitAD Research Group (2014) Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. JAMA 311(7): 682–691
Schmidt R, Hofer E, Bouwman FH et al (2015) EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer’s disease. Eur J Neurol 22(6): 889–898
Schneider LS, Mangialasche F, Andreasen N et al (2014) Clinical trials and late-stage drug development for Alzheimer’s disease: an appraisal from 1984 to 2014. J Intern Med 275(3): 251–283
Stinton C, McKeith I, Taylor JP, Lafortune L et al (2015) Pharmacological management of Lewy body dementia: a systematic review and meta-analysis. Am J Psychiatry 172(8): 731–742
Tan MS, Yu JT, Tan CC et al (2015) Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis. J Alzheimers Dis 43(2): 589–603
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lange-Asschenfeldt, C., Benkert, O. (2017). Antidementiva. In: Benkert, O., Hippius, H. (eds) Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-50333-1_6
Download citation
DOI: https://doi.org/10.1007/978-3-662-50333-1_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-50332-4
Online ISBN: 978-3-662-50333-1
eBook Packages: Medicine (German Language)